Pharma Two B to Host a Virtual KOL Event on Successful Phase III Study Results of P2B001 in Parkinson’s Disease (PD)

  • C. Olanow

Press/Media

Period20 Jan 2022

Media coverage

1

Media coverage

  • TitlePharma Two B to Host a Virtual KOL Event on Successful Phase III Study Results of P2B001 in Parkinson’s Disease (PD)
    Media name/outletPrimeNewswire (Top News)
    Country/TerritoryUnited States
    Date20/01/22
    PersonsC. Olanow
View all 1
View less